TWI369988B - New pharmaceutically active compounds for the treatment of respiratory diseases - Google Patents

New pharmaceutically active compounds for the treatment of respiratory diseases

Info

Publication number
TWI369988B
TWI369988B TW095106149A TW95106149A TWI369988B TW I369988 B TWI369988 B TW I369988B TW 095106149 A TW095106149 A TW 095106149A TW 95106149 A TW95106149 A TW 95106149A TW I369988 B TWI369988 B TW I369988B
Authority
TW
Taiwan
Prior art keywords
treatment
active compounds
pharmaceutically active
respiratory diseases
new pharmaceutically
Prior art date
Application number
TW095106149A
Other languages
English (en)
Other versions
TW200640465A (en
Inventor
Ingo Konetzki
Thierry Bouyssou
Philipp Lustenberger
Andreas Schnapp
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of TW200640465A publication Critical patent/TW200640465A/zh
Application granted granted Critical
Publication of TWI369988B publication Critical patent/TWI369988B/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/04—1,3-Oxazines; Hydrogenated 1,3-oxazines
    • C07D265/12—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
    • C07D265/14—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D265/18—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with hetero atoms directly attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/538—1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with carbocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/16—Central respiratory analeptics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pulmonology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Hydrogenated Pyridines (AREA)
TW095106149A 2005-02-24 2006-02-23 New pharmaceutically active compounds for the treatment of respiratory diseases TWI369988B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102005008921A DE102005008921A1 (de) 2005-02-24 2005-02-24 Neue Arzneimittel zur Behandlung von Atemwegserkrankungen

Publications (2)

Publication Number Publication Date
TW200640465A TW200640465A (en) 2006-12-01
TWI369988B true TWI369988B (en) 2012-08-11

Family

ID=36179764

Family Applications (1)

Application Number Title Priority Date Filing Date
TW095106149A TWI369988B (en) 2005-02-24 2006-02-23 New pharmaceutically active compounds for the treatment of respiratory diseases

Country Status (26)

Country Link
US (3) US20060189605A1 (zh)
EP (1) EP1856070B1 (zh)
JP (1) JP4950075B2 (zh)
KR (1) KR20070110386A (zh)
CN (1) CN101128444A (zh)
AR (1) AR055562A1 (zh)
AT (1) ATE517877T1 (zh)
AU (1) AU2006218010B2 (zh)
BR (1) BRPI0607258A2 (zh)
CA (1) CA2598914A1 (zh)
DE (1) DE102005008921A1 (zh)
DK (1) DK1856070T3 (zh)
EA (1) EA012439B1 (zh)
ES (1) ES2370653T3 (zh)
IL (1) IL185444A0 (zh)
MX (1) MX2007010363A (zh)
MY (1) MY146802A (zh)
NO (1) NO20073176L (zh)
NZ (1) NZ561743A (zh)
PE (1) PE20061097A1 (zh)
PL (1) PL1856070T3 (zh)
TW (1) TWI369988B (zh)
UA (1) UA90504C2 (zh)
UY (1) UY29394A1 (zh)
WO (1) WO2006089859A1 (zh)
ZA (1) ZA200704727B (zh)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102005008921A1 (de) * 2005-02-24 2006-08-31 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Arzneimittel zur Behandlung von Atemwegserkrankungen
US7423146B2 (en) * 2005-11-09 2008-09-09 Boehringer Ingelheim International Gmbh Process for the manufacturing of pharmaceutically active 3,1-benzoxazine-2-ones
PE20080610A1 (es) 2006-08-22 2008-07-15 Boehringer Ingelheim Int Nuevos beta-agonistas enantiomericamente puros, procedimientos para su preparacion y uso como medicamentos
JP2010501520A (ja) * 2006-08-22 2010-01-21 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 光学異性的に純粋なベータ作動薬を含む吸入用粉末製剤
PE20080425A1 (es) * 2006-08-22 2008-06-16 Boehringer Ingelheim Int Formulacion aerosol para la inhalacion de beta-agonistas
UY30552A1 (es) * 2006-08-22 2008-03-31 Boehringer Ingelheim Int Combinaciones farmacologiicas en base a derivados sustituidos de la n-(5-{2-[1,1-dimetil-propilamino]-1-hidroxi-metil}-2-hidroxi-fenil)-metansulfonamida y aplicaciones
EP2093219A1 (de) 2008-02-22 2009-08-26 Boehringer Ingelheim International Gmbh Kristalline, enantiomerenreine Salzform eines Betamimetikums und dessen Verwendung als Arzneimittel
GB201217330D0 (en) * 2012-09-28 2012-11-14 Univ Cardiff Therapeutic for treating inflammatory lung disorders
AU2015370463B2 (en) * 2014-12-24 2020-12-24 Kither Biotech S.R.L. Novel PI3K gamma inhibitor peptide for treatment of respiratory system diseases

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3026534A1 (de) * 1980-07-12 1982-03-18 C.H. Boehringer Sohn, 6507 Ingelheim 3,1-benzoxazin-2-one, ihre herstellung und verwendung
US4460581A (en) * 1982-10-12 1984-07-17 Boehringer Ingelheim Kg (1-Hydroxy-2-amino-alkyl)-substituted benzoxazinones and benzoxazolinones
US4570630A (en) * 1983-08-03 1986-02-18 Miles Laboratories, Inc. Medicament inhalation device
DE3609152A1 (de) * 1986-03-19 1987-09-24 Bayer Ag Verfahren zur herstellung des (-)-antipoden des (e)-1-cyclohexyl-4,4-dimethyl- 3-hydroxy-2-(1,2,4-triazol-1-yl)-pent-1-ens
JP4516064B2 (ja) * 2003-04-04 2010-08-04 ノバルティス アーゲー 気道疾患の処置のためのキノリン−２−オン誘導体
DE102004003428A1 (de) * 2004-01-23 2005-08-11 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue langwirksame Beta-2-Agonisten, und deren Verwendung als Arzneimittel
US7220742B2 (en) * 2004-05-14 2007-05-22 Boehringer Ingelheim International Gmbh Enantiomerically pure beta agonists, process for the manufacture thereof and use thereof as medicaments
DE102005008921A1 (de) * 2005-02-24 2006-08-31 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Arzneimittel zur Behandlung von Atemwegserkrankungen
US7423146B2 (en) * 2005-11-09 2008-09-09 Boehringer Ingelheim International Gmbh Process for the manufacturing of pharmaceutically active 3,1-benzoxazine-2-ones
PE20080425A1 (es) * 2006-08-22 2008-06-16 Boehringer Ingelheim Int Formulacion aerosol para la inhalacion de beta-agonistas
UY30552A1 (es) * 2006-08-22 2008-03-31 Boehringer Ingelheim Int Combinaciones farmacologiicas en base a derivados sustituidos de la n-(5-{2-[1,1-dimetil-propilamino]-1-hidroxi-metil}-2-hidroxi-fenil)-metansulfonamida y aplicaciones

Also Published As

Publication number Publication date
UA90504C2 (ru) 2010-05-11
UY29394A1 (es) 2006-10-02
PE20061097A1 (es) 2006-11-14
WO2006089859A1 (de) 2006-08-31
ZA200704727B (en) 2008-09-25
EA200701615A1 (ru) 2008-02-28
AU2006218010A1 (en) 2006-08-31
DK1856070T3 (da) 2011-09-26
TW200640465A (en) 2006-12-01
JP4950075B2 (ja) 2012-06-13
US20090105236A1 (en) 2009-04-23
EP1856070B1 (de) 2011-07-27
EP1856070A1 (de) 2007-11-21
CA2598914A1 (en) 2006-08-31
EA012439B1 (ru) 2009-10-30
PL1856070T3 (pl) 2011-12-30
ES2370653T3 (es) 2011-12-21
ATE517877T1 (de) 2011-08-15
NZ561743A (en) 2009-09-25
AU2006218010B2 (en) 2013-02-14
NO20073176L (no) 2007-09-17
US20060189605A1 (en) 2006-08-24
MX2007010363A (es) 2007-09-25
BRPI0607258A2 (pt) 2009-08-25
MY146802A (en) 2012-09-28
CN101128444A (zh) 2008-02-20
DE102005008921A1 (de) 2006-08-31
AR055562A1 (es) 2007-08-22
US20110053926A1 (en) 2011-03-03
KR20070110386A (ko) 2007-11-16
JP2008531518A (ja) 2008-08-14
IL185444A0 (en) 2008-01-06

Similar Documents

Publication Publication Date Title
TWI372056B (en) Novel medicament combinations for the treatment of respiratory diseases
IL181049A0 (en) Biphenyloxyacetic acid derivatives for the treatment of respiratory disease
HK1171736A1 (zh) 用於治療呼吸系統疾病的取代酸
IL190338A0 (en) Biphenyloxyacetic acid derivatives for the treatment of respiratory disease
ZA200703601B (en) Medicaments for the treatment or prevention of fibriotic diseases
AP2006003671A0 (en) Sulfonamide derivatives for the treatment of diseases
AP2006003669A0 (en) Sulfonamide derivatives for the treatment of diseases
IL178815A0 (en) The treatment of respiratory disease
IL184934A0 (en) 4-oxoquinazoline-3-yl-benzamide derivatives for the treatment of cytokine diseases
TWI369988B (en) New pharmaceutically active compounds for the treatment of respiratory diseases
EP1962869A4 (en) TREATMENT OF RESPIRATORY DISEASES
IL190652A0 (en) Novel pharmaceutical combinations for the treatment of respiratory disorders
GB0410399D0 (en) The treatment of respiratory disease
EP1838316A4 (en) MACROCYCLIC ANALOGUES USEFUL FOR THE TREATMENT OF IMMUNOREGULATION DISORDERS AND RESPIRATORY DISEASES
HU0500145D0 (en) Composition for the treatment of oral diseases
GB0400802D0 (en) Compounds for the treatment of disease
GB0428218D0 (en) Medicament for Treatment of Inflammatory Diseases
ZA200606780B (en) Compounds for the treatment of diseases
ZA200802948B (en) Biphenyloxyacetic acid derivatives for the treatment of respiratory disease
GB0420867D0 (en) Compounds for the treatment of diseases
IL177531A0 (en) Compounds for the treatment of diseases
GB0425073D0 (en) Compounds for the treatment of diseases
AP2006003743A0 (en) Compounds useful for the treatment of diseases
GB0425064D0 (en) Compounds useful for the treatment of diseases
GB0415352D0 (en) Compounds for the treatment of disease

Legal Events

Date Code Title Description
MM4A Annulment or lapse of patent due to non-payment of fees